|
Video: What is a Stock Split?
|
|
Armata Pharmaceuticals is a biotechnology company focused on the development of therapies for antibiotic-resistant infections using bacteriophage-based technology. Co. has product candidates in clinical and preclinical development for the treatment of Staphylococcus aureus (S. aureus) infections, including methicillin-resistant S. aureus (MRSA), and Pseudomonas aeruginosa (P. aeruginosa) infections. Co.'s product candidates include: AB-SA01, which is used to treat acute and chronic infections caused by S. aureus, including infections caused by MRSA strains of the same bacterium; and AB-PA01, which is a product comprised of four phages, for the treatment of P. aeruginosa infections. According to our APHB split history records, APHB has had 1 split. | |
|
APHB (APHB) has 1 split in our APHB split history database. The split for APHB took place on April 25, 2017. This was a 1 for 10 reverse split, meaning for each 10 shares of APHB owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 100 share position following the split.
When a company such as APHB conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the APHB split history from start to finish, an original position size of 1000 shares would have turned into 100 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into APHB shares, starting with a $10,000 purchase of APHB, presented on a split-history-adjusted basis factoring in the complete APHB split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
10/07/2014 |
|
End date: |
05/09/2019 |
|
Start price/share: |
$1.90 |
|
End price/share: |
$0.32 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-83.16% |
|
Average Annual Total Return: |
-32.17% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$1,684.18 |
|
Years: |
4.59 |
|
|
|
Date |
Ratio |
04/25/2017 | 1 for 10 |
|
|